NCT02424968 2021-06-24
CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma
Stanford University
Phase 2 Completed
Stanford University
Massachusetts General Hospital